Navigation Links
Clinical Trial Participation Unaffected by Disclosure of Investigator's Financial Stake, Food and Drug Law Journal Article Finds
Date:12/18/2007

influenced by the extent of the investigator's financial stake.

On the other hand, offering the students money did significantly affect their willingness to participate. Students who were told they would receive $20 were significantly more likely to want to participate than students offered no money.

Commented Guagnano, "The study suggests that learning about an investigator's financial stake may have a relatively limited impact on deciding whether to participate. If replicated, these findings could affect the way in which clinical study disclosure requirements are established and implemented."

Gibbs added, "There are a number of reasons to mandate disclosures, but this study suggests that disclosure of conflicts may not play a large role in decision-making. Given that some courts have reached decisions based on their believing that knowledge of a financial stake would actually change people's behavior, this study shows that courts need to rely on facts, not assumptions."

The article appears in Vol. 62, Issue 4 of the Food and Drug Law Journal.

For more information or to obtain a copy of the article, contact Michael Levin-Epstein, Editor-in-Chief, FDLI, (202) 222-0897; mdl@fdli.org

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field. For more information, visit http://www.fdli.org


'/>"/>
SOURCE Food and Drug Law Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... MONMOUTH JUNCTION, N.J. , Jan. 23, 2015 ... immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber ... surgery patients, announced the receipt of $385,642, net ... approved participant of the Technology Business Tax Certificate ...
(Date:1/23/2015)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ... and sale of patented biopharmaceutical medicine, modernized traditional Chinese ... today announced the business and development progress at its ... Following the September 2014 JCM application (No. 51268) for ...
(Date:1/22/2015)...  ResMed Inc. (NYSE: RMD ) today announced results ... quarter was $423.0 million, a 10 percent increase compared to ... on a constant currency basis). Net income was $91.2 million, ... December 31, 2013. Diluted earnings per share for the quarter ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... Endpoints Met; Data Demonstrate MoxDuo(TM) IR Provides Better ... BEDMINSTER, N.J., April 20 QRxPharma Limited (ASX: ... completion of a Phase 3 program pilot study ... IR against component doses of morphine and oxycodone. ...
... search for the cause of an inherited form of ... information about how the cancer develops and potentially sheds ... by researchers at Washington University School of ... in Washington, D.C., the International Pleuropulmonary Blastoma Registry at ...
Cached Medicine Technology:QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy 2QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy 3Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers 2Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers 3Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers 4Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers 5
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post ... insurance . , Purchasing an accidental death and dismemberment ... This type of rider provides benefits if the insured dies ... a lesser form of life insurance. , AD&D is ...
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the American ... effort to further promote visibility and adoption of the top ... AMA journals available via its subscription services, EBSCO will now ... , Long known as both a subscription agency and ...
(Date:1/22/2015)... a new blog post explaining the importance of keeping a first ... an auto insurance policy . , Clients who driver safer ... vehicle insurance policies. The safety a vehicle offers from its driver ... this, drivers should always carry a first aid kit in their ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... ORLANDO, Nov. 4 The prevalence of asymptomatic peripheral ... researchers reported at the American Heart Associations Scientific Sessions ... linings of artery walls, restricting blood flow and needed ... of the body. PAD increases the risk of ...
... is symptomless, can lead to heart attack and stroke ... women are suffering from asymptomatic peripheral artery disease, a ... heart attack and stroke, a new study found. ... increase in common cardiovascular risk factors, namely obesity and ...
... been adjusted downward in light of the most recent ... incidence and prevalence of end-stage renal disease (ESRD) in ... at the American Society of Nephrology,s 40th Annual Meeting ... number of patients with ESRD in 2020 is almost ...
... 2008, ORLANDO, Fl., Nov. 3 The American ... Wolters Kluwer,Health, will launch six new journals dedicated to ... cardiology., The new journals are an extension of ... Association, which is ranked,first in the areas of cardiac ...
... and support to do it well, experts say , , ... are choosing to breast-feed. That,s the good news. , ... breast-feeding still falls short of national objectives, often because ... according to lactation experts. , Seventy-four percent of women ...
... Food Detective" video game teaches kids to eat healthy, ... Permanente and the,Golden State Warriors are teaming up to ... kids to get active and an education outreach,program in ... Tuesday, November 6 at the,Warriors-Cleveland Cavaliers game at ORACLE ...
Cached Medicine News:Health News:Asymptomatic peripheral artery disease prevalence is rising 2Health News:Peripheral Artery Disease Up Sharply Among U.S. Women 2Health News:Peripheral Artery Disease Up Sharply Among U.S. Women 3Health News:Study projects 60 percent increase in ESRD population by 2020 2Health News:News from Circulation: Journal of the American Heart Association 2Health News:News from Circulation: Journal of the American Heart Association 3Health News:News from Circulation: Journal of the American Heart Association 4Health News:Successful Breast-Feeding 2Health News:Successful Breast-Feeding 3Health News:Kaiser Permanente and Golden State Warriors Team Up to Fight Childhood Obesity 2Health News:Kaiser Permanente and Golden State Warriors Team Up to Fight Childhood Obesity 3
... software enables the efficient capture of lifestyle, ... has many built-in time saving and error ... name fields and numerous user definable pop ... input. The pre-defined options in the pop ...
... Optimeyes MBA is a complete practice ... specifically for optometrists, opticians and ophthalmologists- ... Macintosh users seeking a graphically rich ... full complement of solid features and ...
... The Advia 120 hematology ... streamline laboratory workflow and ... This analyzer offers a ... assays, meeting the needs ...
The Advia 60 is designed to deliver powerful performance in a small package....
Medicine Products: